Bender Robert & Associates
- SEC CIK
- 0000894300
- Latest filing
- Jul 30, 2026
PFE holding history
Pfizer Inc in every 13F filed by Bender Robert & Associates, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
PFE overviewAll 13F holders of PFEFull Q2 2026 holdings
- Shares (Q1 2024)
- 0
- Sold out in Q1 2024
- Value
- $0
- % of portfolio
- 0.0%
- Quarters held
- 12
- Since Q1 2021
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q1 2024 | 0 | $0 | 0.0% | −7,755−100.0% | Sold out | Holders |
| Q4 2023 | 7,755 | $223.3K | 0.1% | −555−6.7% | Reduced | Holders |
| Q3 2023 | 8,310 | $275.6K | 0.1% | −5,875−41.4% | Reduced | Holders |
| Q2 2023 | 14,185 | $520.3K | 0.1% | −6,035−29.8% | Reduced | Holders |
| Q1 2023 | 20,220 | $825.0K | 0.3% | −410−2.0% | Reduced | Holders |
| Q4 2022 | 20,630 | $1.06M | 0.4% | 00.0% | Unchanged | Holders |
| Q3 2022 | 20,630 | $903.0K | 0.3% | +1,450+7.6% | Added | Holders |
| Q2 2022 | 19,180 | $1.01M | 0.4% | 00.0% | Unchanged | Holders |
| Q1 2022 | 19,180 | $993.0K | 0.3% | +5,763+43.0% | Added | Holders |
| Q4 2021 | 13,417 | $577.0K | 0.2% | 00.0% | Unchanged | Holders |
| Q3 2021 | 13,417 | $577.0K | 0.2% | +30+0.2% | Added | Holders |
| Q2 2021 | 13,387 | $524.0K | 0.1% | +240+1.8% | Added | Holders |
| Q1 2021 | 13,147 | $476.0K | 0.2% | – | – | Holders |
Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.